« Back Urologic Oncology: Seminars and Original Investigations

Article in Press

CA9 as a molecular marker for differential diagnosis of cystic renal tumors

  • Guorong Li, M.D., Ph.D.

      Affiliations

    • Department of Urology, North Hospital, CHU of Saint-Etienne, Faculty of Medicine J Lisfranc, Jean Monnet University, Saint Etienne, France
    • Corresponding Author InformationCorresponding author. Tel.: +0033(0)477828814; fax: +0033(0)477828464
    • G.L. was supported by INCa CLARA and by the project PHRC of the French ministry of health.
    • ,
  • Issam Bilal, M.Sc.

      Affiliations

    • Department of Urology, North Hospital, CHU of Saint-Etienne, Faculty of Medicine J Lisfranc, Jean Monnet University, Saint Etienne, France
    • ,
  • Anne Gentil-Perret, M.D.

      Affiliations

    • Department of Pathology, North Hospital, CHU of Saint-Etienne, Faculty of Medicine J Lisfranc, Jean Monnet University, Saint Etienne, France
    • ,
  • Gang Feng, Ph.D.

      Affiliations

    • Clinical Immunology, North Hospital, CHU of Saint-Etienne, Faculty of Medicine J Lisfranc, Jean Monnet University, Saint Etienne, France
    • G.F. was supported by le Comité de la Loire de la Ligue Nationale Contre le Cancer.
    • ,
  • An Zhao, M.Sc.

      Affiliations

    • Department of Urology, North Hospital, CHU of Saint-Etienne, Faculty of Medicine J Lisfranc, Jean Monnet University, Saint Etienne, France
    • ,
  • Michel Peoc'h, M.D., Ph.D.

      Affiliations

    • Department of Pathology, North Hospital, CHU of Saint-Etienne, Faculty of Medicine J Lisfranc, Jean Monnet University, Saint Etienne, France
    • ,
  • Christian Genin, M.D., Ph.D.

      Affiliations

    • Clinical Immunology, North Hospital, CHU of Saint-Etienne, Faculty of Medicine J Lisfranc, Jean Monnet University, Saint Etienne, France
    • ,
  • Jacques Tostain, M.D.

      Affiliations

    • Department of Urology, North Hospital, CHU of Saint-Etienne, Faculty of Medicine J Lisfranc, Jean Monnet University, Saint Etienne, France
    • ,
  • Marc Gigante, M.D., Ph.D.

      Affiliations

    • Department of Urology, North Hospital, CHU of Saint-Etienne, Faculty of Medicine J Lisfranc, Jean Monnet University, Saint Etienne, France

Received 12 February 2010 ,Revised 6 April 2010 ,Accepted 28 April 2010. Published online 07 September 2010 Corrected Proof

References 

  1. Song C, Min GE, Song K, et al. Differential diagnosis of complex cystic renal mass using multiphase computerized tomography. J Urol. 2009;181:2446–2450
  2. Adey GS, Pedrosa I, Rofsky NM, et al. Lower limits of detection using magnetic resonance imaging for solid components in cystic renal neoplasms. Urology. 2008;71:47–51
  3. Aubert S, Zini L, Delomez J, et al. Cystic renal cell carcinomas in adults. Is preoperative recognition of multilocular cystic renal cell carcinoma possible? J Urol. 2005;174:2115–2119
  4. Bosniak MA. The current radiological approach to renal cysts. Radiology. 1986;158:1–10
  5. Long JA, Neuzillet Y, Correas JM, et al. Atypical cysts and cystic tumours of the kidney: Histological, radiological, and surgical considerations. Conclusions of the AFU 2007 Forum. Prog Urol. 2009;19:8–14
  6. Lopez-Beltran A, Scarpelli M, Montironi R, et al. 2004 WHO classification of the renal tumors of the adults. Eur Urol. 2006;49:798–805
  7. Liao SY, Aurelio ON, Jan K, et al. Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney. Cancer Res. 1997;57:2827–2831
  8. Li G, Cuilleron M, Gentil-Perret A, et al. Rapid and sensitive detection of messenger RNA expression for molecular differential diagnosis of renal cell carcinoma. Clin Cancer Res. 2003;9:6441–6446
  9. Li G, Feng G, Gentil-Perret A, et al. Serum carbonic anhydrase 9 level is associated with postoperative recurrence of conventional renal cell cancer. J Urol. 2008;180:510–513
  10. Li G, Cuilleron M, Cottier M, et al. The use of MN/CA9 gene expression in identifying malignant solid renal tumors. Eur Urol. 2006;49:401–405
  11. Li G, Feng G, Cuilleron M, et al. CA9 level in renal cyst fluid: A possible molecular diagnosis of malignant tumours. Histopathology. 2009;54:880–884
  12. Zhou GX, Ireland J, Rayman P, et al. Quantification of Carbonic anhydrase IX expression in serum and tissue of renal cell carcinoma patients using enzyme-linked immunosorbent assay: Prognostic and diagnostic potentials. Urology. 2010;75:115–123
  13. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol. 1982;6:655–663
  14. Wykoff CC, Beasley NJ, Watson PH, et al. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res. 2000;60:7075–7083
  15. Gupta R, Balzer B, Picken M, et al. Diagnostic implications of transcription factor Pax 2 protein and transmembrane enzyme complex carbonic anhydrase IX immunoreactivity in adult epithelial neoplasms. Am J Surg Pathol. 2009;33:241–247
  16. Sandlund J, Oosterwijk E, Grankvist K, et al. Prognostic impact of carbonic anhydrase IX expression in human renal cell carcinoma. BJU Int. 2007;100:556–560
  17. Bui MH, Seligson D, Han KR, et al. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: Implications for prognosis and therapy. Clin Cancer Res. 2003;9:802–811
  18. Nassir A, Jollimore J, Gupta R, et al. Multilocular cystic renal cell carcinoma: A series of 12 cases and review of the literature. Urology. 2002;60:421–427
  19. Suzigan S, Lopez-Beltran A, Montironi R, et al. Multilocular cystic renal cell carcinoma: A report of 45 cases of a kidney tumor of low malignant potential. Am J Clin Pathol. 2006;125:217–222
  20. Mukhopadhyay S, Valente AL, de la Roza G. Cystic nephroma: A histologic and immunohistochemical study of 10 cases. Arch Pathol Lab Med. 2004;128:1404–1411
  21. Grignon DJ, Bismar TA, Bianco E, et al. VHL gene mutation in multilocular cystic renal cell carcinoma: Evidence in support of its classification as a type of clear cell renal cell carcinoma. Mod pathol. 2004;17(Suppl. 1):154A
  22. Israel GM, Bosniak MA. An update of the Bosniak renal cyst classification system. Urology. 2005;66:484–488
  23. Harisinghani MG, Maher MM, Gervais DA, et al. Incidence of malignancy in complex cystic renal masses (Bosniak category III): Should imaging-guided biopsy precede surgery?. AJR Am J Roentgenol. 2003;180:755–758
  24. Hazelton D, Nicosia RF, Nicosia SV. Vascular endothelial growth factor levels in ovarian cyst fluid correlate with malignancy. Clin Cancer Res. 1999;5:823–829
  25. Wu H, Yan LN, Cheng NS, et al. Role of cystic fluid in diagnosis of the pancreatic cystadenoma and cystadenocarcinoma. Hepatogastroenterology. 2007;54:1915–1918

☆ Financial support for this research was provided by CHU de Saint-Etienne.

PII: S1078-1439(10)00124-9

doi: 10.1016/j.urolonc.2010.04.014

« Back Urologic Oncology: Seminars and Original Investigations

Article in Press

Article Tools

* Image Usage & Resolution